| Previous close | 18.05 |
| Open | 18.30 |
| Bid | 0.00 |
| Ask | 0.00 |
| Strike | 165.00 |
| Expiry date | 2026-01-16 |
| Day's range | 18.05 - 18.35 |
| Contract range | N/A |
| Volume | |
| Open interest | N/A |
PR NewswireAbbVie Completes Acquisition of Landos Biopharma
AbbVie (NYSE: ABBV) announced today that it has completed its acquisition of Landos Biopharma, Inc. (NASDAQ: LABP). With the completion of the acquisition, Landos is now part of AbbVie.
ZacksWhy AbbVie (ABBV) is a Top Value Stock for the Long-Term
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
ZacksLilly (LLY) Hits Record High on Crohn's Disease Study Data
Eli Lilly's (LLY) stock hits an all-time high after announcing detailed results from a late-stage study on mirikizumab in Crohn's disease.
© 2024 Yahoo. All rights reserved.